EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 148 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $7,000 | 0.0% | 113 | -7.4% | 0.00% | – |
| Q3 2019 | $7,000 | +250.0% | 122 | +190.5% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 42 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | -33.3% | 42 | -44.0% | 0.00% | – |
| Q4 2018 | $3,000 | -70.0% | 75 | -47.2% | 0.00% | – |
| Q3 2018 | $10,000 | -94.4% | 142 | -95.8% | 0.00% | -100.0% |
| Q2 2018 | $178,000 | 0.0% | 3,399 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $178,000 | -0.6% | 3,399 | +1.5% | 0.00% | 0.0% |
| Q4 2017 | $179,000 | -11.8% | 3,349 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $203,000 | -22.2% | 3,349 | +0.9% | 0.00% | -33.3% |
| Q2 2017 | $261,000 | -4.7% | 3,318 | +0.5% | 0.00% | 0.0% |
| Q1 2017 | $274,000 | +4.6% | 3,300 | 0.0% | 0.00% | -25.0% |
| Q4 2016 | $262,000 | +13.4% | 3,300 | 0.0% | 0.00% | +33.3% |
| Q3 2016 | $231,000 | +75.0% | 3,300 | -1.5% | 0.00% | +50.0% |
| Q2 2016 | $132,000 | +6500.0% | 3,350 | +6600.0% | 0.00% | – |
| Q1 2016 | $2,000 | -50.0% | 50 | 0.0% | 0.00% | – |
| Q4 2015 | $4,000 | -87.9% | 50 | -87.7% | 0.00% | -100.0% |
| Q2 2015 | $33,000 | – | 405 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudson Executive Capital LP | 1,323,794 | $79,534,000 | 3.54% |
| Park West Asset Management LLC | 1,171,880 | $70,406,000 | 2.96% |
| Matarin Capital Management, LLC | 170,008 | $10,214,000 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 140,014 | $8,412,000 | 0.82% |
| Capital Impact Advisors, LLC | 33,725 | $2,026,000 | 0.71% |
| U S GLOBAL INVESTORS INC | 18,800 | $1,130,000 | 0.51% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 187,989 | $11,294,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,442,000 | 0.34% |
| GLOBEFLEX CAPITAL L P | 18,751 | $1,127,000 | 0.21% |
| Foundry Partners, LLC | 70,357 | $4,227,000 | 0.16% |